Comparative performance of tuberculin skin test, Quanti FERON-TB-Gold in tube assay, and T-SpotTB test in contact investigations for tuberculosis

Chest

Volumn 135, Issue 4, 2009, Pages 1010-1018

  Diel, Roland ^a   Loddenkemper, Robert ^b   Meywald Walter, Karen ^c   Gottschalk, Rene ^d   Nienhaus, Albert ^e  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Lungenklinik Heckeshorn   (Germany)

^c Public Health Department Hamburg Central   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services   (Germany)

Author keywords

Independent risk factor; Interferon ; Latent infection; Release assay; Tuberculin skin test; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC TEST; FEMALE; HUMAN; INFANT; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE ASSAY; RISK FACTOR; SCHOOL CHILD; T SPOT; TUBERCULIN TEST; TUBERCULOSIS; ANALYTICAL EQUIPMENT; COMPARATIVE STUDY; CONTACT EXAMINATION; ISOLATION AND PURIFICATION; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; FEMALE; HUMANS; INFANT; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

EID: 64749087194     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2048     Document Type: Article

References (36)

1. Roland.Diel@uni-duesseldorf.de 1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161:S221-S247
2. Rothel JS, Andersen P. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev Anti Infect Ther 2005; 3:981-993
3. Berkel GM, Cobelens FG, de Vries G, et al. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis 2005; 9:310-316
4. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-7-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:59-64
5. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361:1168-1173
6. Houk VN, Baker JH, Sorensen K, et al. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health 1968; 16:26-35
7. Sultan L, Nyka W, Mills C, et al. Tuberculosis disseminators: a study of the variability of aerial infectivity of tuberculosis patients. Am Rev Respir Dis 1960; 82:358-369
8. Marks SM, Taylor Z, Qualls NL, et al. Outcomes of contact investigations of infectious tuberculosis patients. Am J Respir Crit Care Med 2000; 162:2033-2038
9. Reichler MR, Reves R, Bur S, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA 2002; 287:991-995
10. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353:444-449
11. Loudon RG, Spohn SK. Cough frequency and infectivity in patients with pulmonary tuberculosis. Am Rev Respir Dis 1969; 99:109-111
12. Kenyon TA, Valway SE, Ihle WW, et al. Transmission of multi-drug resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med 1996; 334:933-938
13. Behr A, Hopewell PC, Paz EA, et al. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158:465-469
14. Pai M, Zwerling A, Menzies D. Systematic review: T-cell- based assays for the diagnosis of latent tuberculosis infection; an update. Ann Intern Med 2008; 149:177-184
15. Dominguez J, Ruiz-Manzano J, De Souza-Galvao M, et al. Comparison of two commercially available γ interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 2008; 15:168-171
16. Lee JY, Choi HJ, Park IN, et al. Comparison oftwo commercial interferon gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28:24-30
17. Goletti D, Vincenti D, Carrara S, et al. Selected RD1 peptides for active tuberculosis diagnosis: comparison of a γ interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005; 12:1311-1316 18. Vincenti D, Carrara S, Butera O, et al. Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol 2007; 150:91-98
18. Detjen AK, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45:322-328
19. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens. Am J Respir Crit Care Med 2007; 175:282-287
20. Arend S, Thjjsen SF, Leyten EM, et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175:618-627
21. National Institute for Health and Clinical Excellence. Clinical guideline 33: tuberculosis; clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Available at: www.nice.org.uk/CG033. Accessed September 1, 2008
22. Bericht zur Epidemiologie der Tuberkulose in Deutschland fur 2005. Berlin, Germany: Robert Koch Institut, 2007
23. Statistische Amter des Bundes und der Lander: Gebiet und Bevölkerung: Auslandische Bevolkerung. Wiesbaden, Germany: Statistisches Bundesamt, 2007
24. German Central Committee Against Tuberculosis. Rich- tlinien fur die Umgebungs-untersuchungen bei Tuberkulose [Guidelines for environmental contact tracing in tuberculosis]. Gesundheitswesen 1996; 58:657-665
25. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006; 174:736-742
26. Hirsch CS, Toossi Z, Othieno C, et al. Depressed T-cell interferon-γ responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999; 180:2069-2073
27. Diel R, Forssbohm M, Loytved G, et al. German Central Committee Against Tuberculosis. Empfehlungen fur die Umgebungsuntersuchungen bei Tuberkulose [Recom-mendations for environmental contact tracing in tuberculosis]. Pneumologie 2007; 58:657-665
28. Diel R, Nienhaus A, Loddenkemper R. Cost-effectiveness of interferon-γ release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007; 131:424-434
29. Wrighton-Smith P, Zellweger J-P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 2006; 28:45-50
30. Diel R, Loddenkemper R, Meywald-Walter K, et al. Predictive value of a whole-blood IFN-γ assay for the development of active TB disease. Am J Respir Crit Care Med 2008; 177:1164-1170
31. Weiss S. Contact investigations: how do they need to be designed for the 21st century? Am J Respir Crit Care Med 2002; 166:1016-1017
32. Leung CC, Bailey WC, Yew WW. Screening contacts of tuberculosis: overcoming obstacles with an old tool. Am J Respir Crit Care Med 2008; 177:939-940
33. Aissa K, Madhi F, Ronsin N, et al. Evaluation of a model for efficient screening of tuberculosis contact subjects. Am J Respir Crit Care Med 2008; 177:1041-1047
34. Diel R, Seidler A, Nienhaus A, et al. Occupational risk of tuberculosis transmission in a low incidence area. Respir Res 2005; 6:35
35. Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Morb Mortal Wkly Rep 2005; 54(RR-15):1-37
36. Snider DE Jr, Kelly GD, Cauthen GM, et al. Infection and disease among contacts of tuberculosis cases with drug resistant and drug-susceptible bacilli. Am Rev Respir Dis 1985; 132:125-132